TScan Therapeutics, Inc. · NASDAQ:TCRX
TScan Therapeutics, Inc. shareholders
As of Sep 30, 2026, 49 institutions reported holding TScan Therapeutics, Inc., 51.6% of its shares. Largest: Lynx1 Capital Management LP, Bvf Inc and Boothbay Fund Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of TScan Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Lynx1 Capital Management LP | 8.02M | 12.6% | no change | Nov 16, 2026 |
| Bvf Inc | 5.56M | 8.8% | no change | Nov 16, 2026 |
| Boothbay Fund Management, LLC | 3.4M | 5.4% | +2.63M | Nov 16, 2026 |
| Vanguard | 2.89M | 4.5% | +350K | Nov 13, 2026 |
| Baker Bros. Advisors LP | 2.78M | 4.4% | no change | Nov 16, 2026 |
| Acadian Asset Management LLC | 1.69M | 2.7% | +387K | Nov 9, 2026 |
| Two Sigma | 1.66M | 2.6% | −291K | Nov 16, 2026 |
| Deer Management Co. LLC | 1.25M | 2.0% | no change | Nov 16, 2026 |
| Renaissance Technologies | 1.21M | 1.9% | −119K | Nov 12, 2026 |
| DC Funds, LP | 630K | 0.99% | no change | Nov 13, 2026 |